---
figid: PMC8131909__WJGO-13-366-g001
figtitle: 'Molecular-targeted therapy toward precision medicine for gastrointestinal
  caner: Current progress and challenges'
organisms:
- Homo sapiens
- Mus musculus
- Human gammaherpesvirus 4
- Bikinia letestui
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8131909
filename: WJGO-13-366-g001.jpg
figlink: /pmc/articles/PMC8131909/figure/F1/
number: F1
caption: 'Ongoing gastrointestinal cancer clinical trials. A schematic representation
  of the therapies targeting the key oncogenic signaling pathways in gastrointestinal
  cancer. These therapies include agents that specifically inhibit components and
  antibodies of the growth factor receptors such as Epidermal growth factor receptor,
  RAS/BRAF/mitogen-activated protein kinase, Human epidermal growth factor 2, mesenchymal-epithelial
  transition, SHP2, Bruton tyrosine kinase, anaplastic lymphoma kinase, ﬁbroblast
  growth factor recepto, janus kinase - signal transducer and activator of transcription,
  vascular endothelial growth factor receptor, phosphoinositide 3-kinase/protein kinase
  B/mammalian target of rapamycin, and tumor growth factor-β pathway; epigenetic regulators
  such as poly (ADP-ribose) polymerases, cyclin-dependent kinase, and histone deacetylases,
  and other family members such as WNT, dickkopf-1, hedgehog, CLDN 18.2, and cadherin.
  EGFR: Epidermal growth factor receptor; HER2/3/4: Human epidermal growth factor
  2/3/4; MET: Mesenchymal-epithelial transition; ALK: Anaplastic lymphoma kinase;
  FGFR: Fbroblast growth factor receptor; VEGFR: Vascular endothelial growth factor
  receptor; MEK: Mitogen-activated protein kinase; DKK1: Dickkopf-1; ERK: Extracellular
  signal-regulated kinase; CKD4/6: Cyclin-dependent kinase 4/6; HDAC: Histone deacetylases;
  PARP: Poly (ADP-ribose) polymerases; mTOR: Mammalian target of rapamycin ; AKT:
  Protein kinase B; PI3K Phosphoinositide 3-kinase; STAT: Signal transducer and activator
  of transcription; JAK Janus kinase; BKT: Bruton tyrosine kinase; TGF-β: Tumor growth
  factor-β; CLDN: Claudin.'
papertitle: 'Molecular-targeted therapy toward precision medicine for gastrointestinal
  caner: Current progress and challenges.'
reftext: Tasuku Matsuoka, et al. World J Gastrointest Oncol. 2021 May 15;13(5):366-390.
year: '2021'
doi: 10.4251/wjgo.v13.i5.366
journal_title: World Journal of Gastrointestinal Oncology
journal_nlm_ta: World J Gastrointest Oncol
publisher_name: Baishideng Publishing Group Inc
keywords: Gastrointestinal cancer | Esophageal cancer | Gastric cancer | Colorectal
  cancer | Targeted therapy | Precision medicine
automl_pathway: 0.8949696
figid_alias: PMC8131909__F1
figtype: Figure
redirect_from: /figures/PMC8131909__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8131909__WJGO-13-366-g001.html
  '@type': Dataset
  description: 'Ongoing gastrointestinal cancer clinical trials. A schematic representation
    of the therapies targeting the key oncogenic signaling pathways in gastrointestinal
    cancer. These therapies include agents that specifically inhibit components and
    antibodies of the growth factor receptors such as Epidermal growth factor receptor,
    RAS/BRAF/mitogen-activated protein kinase, Human epidermal growth factor 2, mesenchymal-epithelial
    transition, SHP2, Bruton tyrosine kinase, anaplastic lymphoma kinase, ﬁbroblast
    growth factor recepto, janus kinase - signal transducer and activator of transcription,
    vascular endothelial growth factor receptor, phosphoinositide 3-kinase/protein
    kinase B/mammalian target of rapamycin, and tumor growth factor-β pathway; epigenetic
    regulators such as poly (ADP-ribose) polymerases, cyclin-dependent kinase, and
    histone deacetylases, and other family members such as WNT, dickkopf-1, hedgehog,
    CLDN 18.2, and cadherin. EGFR: Epidermal growth factor receptor; HER2/3/4: Human
    epidermal growth factor 2/3/4; MET: Mesenchymal-epithelial transition; ALK: Anaplastic
    lymphoma kinase; FGFR: Fbroblast growth factor receptor; VEGFR: Vascular endothelial
    growth factor receptor; MEK: Mitogen-activated protein kinase; DKK1: Dickkopf-1;
    ERK: Extracellular signal-regulated kinase; CKD4/6: Cyclin-dependent kinase 4/6;
    HDAC: Histone deacetylases; PARP: Poly (ADP-ribose) polymerases; mTOR: Mammalian
    target of rapamycin ; AKT: Protein kinase B; PI3K Phosphoinositide 3-kinase; STAT:
    Signal transducer and activator of transcription; JAK Janus kinase; BKT: Bruton
    tyrosine kinase; TGF-β: Tumor growth factor-β; CLDN: Claudin.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Dkk1
  - Egfr
  - Gm12892
  - Shh
  - Axin1
  - Apc
  - Gsk3b
  - Erbb2
  - Ctnnb1
  - Mdk
  - Zhx2
  - Ptpn11
  - ras
  - Hras
  - Kras
  - Rem1
  - Hsp90ab1
  - Hsp90aa1
  - Hsp84-2
  - Hsp84-3
  - Hsp86-ps2
  - Hsp86-ps1
  - Met
  - Ephb2
  - Mapk1
  - Btk
  - Mtor
  - Cdk6
  - Cdk4
  - Pik3r1
  - Akt1
  - Alk
  - Cdkn2a
  - Cyp2b10
  - Rbm14
  - Parp1
  - Crebbp
  - Pag1
  - Cytip
  - Smad2
  - Smad3
  - Smad4
  - Tgfb1
  - Ltbp1
  - Ptch1
  - Smo
  - Smox
  - Tgfbr1
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - DKK1
  - EGFR
  - CDH1
  - CDH10
  - CDH11
  - CDH12
  - CDH13
  - CDH15
  - CDH16
  - CDH17
  - CDH18
  - CDH19
  - CDH2
  - CDH20
  - CDH22
  - CDH24
  - CDH3
  - CDH4
  - CDH5
  - CDH6
  - CDH7
  - CDH8
  - CDH9
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - ADAR
  - DVL1P1
  - AXIN1
  - AXIN2
  - APC
  - PROC
  - GSK3A
  - GSK3B
  - ERBB2
  - CTNNB1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PTPN11
  - KRAS
  - HRAS
  - NRAS
  - HSP90AA1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - MET
  - EPHB2
  - MAPK1
  - MAPK3
  - BTK
  - MTOR
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - CDK6
  - CDK4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - ALK
  - CDKN2A
  - H3P10
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK5
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - KDR
  - FLT1
  - FLT4
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SMAD2
  - SMAD3
  - SMAD4
  - GLI1
  - DHH
  - IHH
  - SHH
  - TGFB1
  - TGFB2
  - TGFB3
  - PTCH1
  - SMO
  - SMOX
  - TGFBR1
  - .na.character
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - CkIalpha
  - gish
  - dsh
  - Axn
  - Apc2
  - Fs(3)Apc
  - sgg
  - arm
  - Dsor1
  - Mtk
  - Raf
  - csw
  - Ras64B
  - Ras85D
  - Hsp83
  - Gp93
  - Erk7
  - rl
  - Tor
  - rb
  - ebi
  - E2f2
  - E2f1
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Zdhhc8
  - Arpc5
  - Su(osk)P16
  - Parp
  - btl
  - htl
  - CBP
  - nej
  - eIF4E1
  - Stat92E
  - Pvr
  - hop
  - bsk
  - Med
  - Gli
  - ci
  - dpp
  - gbb
  - put
  - mav
  - ptc
  - smo
  - sm
---
